German News Today
SEE OTHER BRANDS

Your daily news update on Germany

German News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German News Today.

Press releases published on June 23, 2025

New Wave Announces Non-Brokered Private Placement of Units

New Wave Announces Non-Brokered Private Placement of Units

Vancouver, BC, June 23, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp., to be renamed Humanoid Global Holdings Corp., (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it will proceed with a non-brokered private …

Sono Group N.V.’s CEO Shareholder Update – June 2025

Sono Group N.V.’s CEO Shareholder Update – June 2025

West Palm Beach, FL, June 23, 2025 (GLOBE NEWSWIRE) -- The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as “Sono Group” or “Sono”, parent company to Sono Motors GmbH or “Sono Motors”) today issued a shareholder update from …

Goliath Intersects 6.31 g/t AuEq Over 14.35 Meters In RIRG Feeder Dyke, The First Of Multiple Relogged Holes Containing Abundant Visible Gold Substantially Expanding High-Grade Gold Potential On The Surebet Discovery That Remains Wide Open, Golddigger…

Goliath Intersects 6.31 g/t AuEq Over 14.35 Meters In RIRG Feeder Dyke, The First Of Multiple Relogged Holes Containing Abundant Visible Gold Substantially Expanding High-Grade Gold Potential On The Surebet Discovery That Remains Wide Open, Golddigger…

Drill hole GD-22-64 assayed 6.31 g/t AuEq Over 14.35 Meters Including 11.36 g/t AuEq Over 7.85 Meters from a gold-rich intrusive feeder dyke and is the first of multiple drill holes containing gold visible to the naked eye over broad intervals identified …

ITM and Debiopharm Announce First Patient Imaged in New Study Arm of Phase 1/2 Trial Evaluating ITM-94 as Diagnostic Agent for Clear Cell Renal Cell Carcinoma (ccRCC)

ITM and Debiopharm Announce First Patient Imaged in New Study Arm of Phase 1/2 Trial Evaluating ITM-94 as Diagnostic Agent for Clear Cell Renal Cell Carcinoma (ccRCC)

New study arm (Part D) is part of the broad clinical development plan of the ITM-91/ITM-94 theranostic program in patients with Carbonic Anhydrase IX (CAIX)-expressing tumors Part D builds on promising imaging data demonstrated in Part A of the study for …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions